Zobrazeno 1 - 10 of 19 pro vyhledávání: '"Marcoli Cyrille"'
1
Akademický článek
Development and validation of the Crohn’s disease patient-reported outcomes signs and symptoms (CD-PRO/SS) diary
Autor: Peter D. R. Higgins, Gale Harding, Nancy K. Leidy, Kendra DeBusk, Donald L. Patrick, Hema N. Viswanathan, Kristina Fitzgerald, Sarah M. Donelson, Marcoli Cyrille, Brian G. Ortmeier, Hilary Wilson, Dennis A. Revicki, Gary Globe
Publikováno v: Journal of Patient-Reported Outcomes, Vol 2, Iss 1, Pp 1-10 (2018)
Abstract Background The clinical course of Crohn’s disease (CD) and the effect of its treatment are monitored through patient-reported signs and symptoms (S&S), and endoscopic evidence of inflammation. The Crohn’s Disease Patient-reported Outcome
Externí odkaz: https://doaj.org/article/7eb31ad3a3f444e29c26c8e50232e7d3
Zobrazit plný text záznamu
2
Evolocumab in HIV-Infected Patients With Dyslipidemia
Autor: Franck Boccara, Princy N. Kumar, Bruno Caramelli, Alexandra Calmy, J. Antonio G. López, Sarah Bray, Marcoli Cyrille, Robert S. Rosenson, David Baker, Mark Bloch, Robert Finlayson, Jennifer Hoy, Kenneth Koh, Norman Roth, Stephane De Wit, Eric Florence, Linos Vandekerckhove, Jose Valdez Ramalho Madruga, Sandra Wagner Cardoso, Greg Bondy, Michael Gill, George Tsoukas, Sylvie Trottier, Marek Smieja, Christine Katlama, Fabrice Bonnet, Francois Raffi, Laurent Cotte, Jean-Michel Molina, Jacques Reynes, Antonios Papadopoulos, Simeon Metallidis, Vassilios Paparizos, Vasileios Papastamopoulos, Cristina Mussini, Massimo Galli, Andrea Antinori, Antonio Di Biagio, Pierluigi Viale, Andrzej Horban, Nuno Marques, Daniel Coutinho, Joaquim Oliveira, Paula Freitas, Liliana-Lucia Preotescu, Iosif Marincu, Rodica Silaghi, Sorin Rugina, Noluthando Mwelase, Sheena Kotze, Jose Ignacio Bernardino de la Serna, Vicente Estrada Perez, Esteban Martinez, Adrian Curran, Dominique Laurent Braun, Enos Bernasconi, Matthias Cavassini, John Walsh, Julie Fox, Graeme Moyle, Robert Rosenson, Jamie Morano, Jason Baker, Gerald Pierone, Carl Fichtenbaum, Paul Benson, Deborah Goldstein, Joseph Sacco, Princy Kumar, Robert Grossberg, Kara Chew, Christopher DeFilippi, Vilma Drelichman, Norman Markowitz, David Parenti, Katherine Doktor, Paul Thompson
Publikováno v: Journal of the American College of Cardiology. 75:2570-2584
Background People living with HIV (PLHIV) are at increased risk of atherosclerotic cardiovascular disease (ASCVD) and prone to statin-related adverse events from drug-drug interactions with certain antiretroviral regimens. Objectives This study sough
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::de4c638f1c99a5aa5c7fc8cce88a955f
https://doi.org/10.1016/j.jacc.2020.03.025
Zobrazit plný text záznamu
3
Evolocumab vs. Ezetimibe in Statin-Intolerant Hyperlipidemic Japanese Patients: Phase 3 GAUSS-4 Trial
Autor: Kouji Kajinami, Junichiro Shimauchi, Ikuo Inoue, Marcoli Cyrille, Chen Lu, Hyoe Inomata, Shinji Koba
Publikováno v: Journal of Atherosclerosis and Thrombosis
Aim: In patients with hyperlipidemia, intolerance to statins presents a challenge in reducing the risk of events associated with cardiovascular disease. This phase 3, randomized, double-blind trial in Japanese patients with statin intolerance aimed t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3813b583674fd824913fd795e5b46c49
http://europepmc.org/articles/PMC7242224
Zobrazit plný text záznamu
4
Long-Term Treatment With Evolocumab Among Japanese Patients ― Final Report of the OSLER Open-Label Extension Studies ―
Autor: Hyoe Inomata, Chen Lu, Andrew Hamer, Atsushi Hirayama, Arihiro Kiyosue, Tamio Teramoto, Andrea Ruzza, Shizuya Yamashita, Masayuki Yoshida, Marcoli Cyrille
Publikováno v: Circulation Journal. 83:971-977
Background Treatment with evolocumab reduces mean low-density lipoprotein cholesterol (LDL-C) up to 75% and cardiovascular events by 16% in the first year and 25% thereafter. Methods and Results: Japanese patients with hypercholesterolemia enrolled i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51a5cc16b14ec7f8a7b86d42ebd95034
https://doi.org/10.1253/circj.cj-19-0139
Zobrazit plný text záznamu
5
Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia: BEIJERINCK study design and baseline characteristics
Autor: Alexandra Calmy, Sarah Bray, J. Antonio G. López, Bruno Caramelli, Robert S. Rosenson, Marcoli Cyrille, Franck Boccara, Princy Kumar
Publikováno v: American Heart Journal
American Heart Journal, Elsevier, 2020, 220, pp.203-212. ⟨10.1016/j.ahj.2019.11.004⟩
American Heart Journal, Vol. 220 (2020) pp. 203-212
International audience; Background: People living with human immunodeficiency virus (PLHIV) are at higher risk of atherosclerotic cardiovascular disease (ASCVD) due to traditional and HIV- or antiretroviral treatment (ART)-related risk factors. The u
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66cde07c1e2a7108649ad552496f2518
https://hal.sorbonne-universite.fr/hal-02498275
Zobrazit plný text záznamu
7
EVOLOCUMAB USE IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS AND DYSLIPIDEMIA: PRIMARY RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (BEIJERINCK)
Autor: Alexandra Calmy, Franck Boccara, Robert Rosenson, Marcoli Cyrille, Sarah Bray, J. Antonio G. López, Bruno Caramelli, Princy Kumar
Publikováno v: Journal of the American College of Cardiology. 75:1832
People living with human immunodeficiency virus (PLHIV) are at increased risk of cardiovascular disease due to metabolic abnormalities, chronic inflammation and immune dysregulation. PLHIV may receive suboptimal lipid-lowering therapy because of drug
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b4e0636f34eae6906bf1d30af1916faf
https://doi.org/10.1016/s0735-1097(20)32459-1
Zobrazit plný text záznamu
8
Development and validation of the Crohn’s disease patient-reported outcomes signs and symptoms (CD-PRO/SS) diary
Autor: Hema N. Viswanathan, Donald L. Patrick, Gale Harding, Sarah Donelson, Dennis A. Revicki, Nancy Kline Leidy, Kristina Fitzgerald, Kendra DeBusk, Peter D.R. Higgins, Marcoli Cyrille, Brian G. Ortmeier, Hilary Wilson
Publikováno v: Journal of Patient-Reported Outcomes
Journal of Patient-Reported Outcomes, Vol 2, Iss 1, Pp 1-10 (2018)
Background The clinical course of Crohn’s disease (CD) and the effect of its treatment are monitored through patient-reported signs and symptoms (S&S), and endoscopic evidence of inflammation. The Crohn’s Disease Patient-reported Outcomes Signs a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd2f62508f09c435aebace66d43a0f51
https://doi.org/10.1186/s41687-018-0044-7
Zobrazit plný text záznamu
9
Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis
Autor: Jun Yang, Barbara A. Sullivan, Mark Berner Hansen, William J. Sandborn, Marcoli Cyrille, Christine M. Evangelista, Michael Boedigheimer, Martha L. Cruz, Severine Vermeire, Walter Reinisch, Gerhard Rogler, Brian G. Feagan, Lubna Abuqayyas, Edward V. Loftus
Publikováno v: Gastroenterology. 156(4)
BACKGROUND & AIMS: The α4β7 integrin is a validated target in inflammatory bowel disease. This randomized, phase 2b, placebo-controlled, double-blind study evaluated the efficacy and safety of the anti-α4β7 antibody abrilumab in patients with mod
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e9c705c5ff3be8481f7e1394f22e2b8
https://pubmed.ncbi.nlm.nih.gov/30472236
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje